The Maryland attorney general’s office on Thursday accused the manufacturer of a powerful fentanyl spray of violating consumer protection laws thousands of times by engaging in a “deceptive scheme” to buy the help of doctors and deceive insurance companies to boost sales.
The attorney general’s office is seeking $20 million in various penalties from Arizona-based Insys Therapeutics for allegedly paying doctors thousands of dollars as rewards for writing prescriptions to treat conditions other than the drug’s approved purpose of managing the pain of cancer patients.
The money was supposedly for speaking engagements that the attorney general’s office alleges were often alcohol-fueled social events held at bars, strip clubs and private hotel rooms.
To convince reluctant insurers to cover the costs of the prescriptions, company employees were trained to lie about why the drug was being used, the attorney general’s office alleges in legal papers filed Thursday.
Insys reaped more than $20 million in revenue from 3,000 prescriptions written in Maryland, according to the “statement of charges” filed with the state’s consumer protection agency.
Capital Gazette Op Ed – Brian Frosh: State has taken steps to curb gun violence; Congress needs to do more
The horror and uncertainty we feel in the wake of the attack in the Capital Gazette newsroom has gripped our state, and, like all Marylanders, I share in the grief. Words of elected leaders will [...]
Maryland plans to take the Trump administration to federal appeals court now that the Environmental Protection Agency has rejected the state's demands that it do more to limit coal power plant emissions in upwind states. [...]
Maryland Attorney General Brian E. Frosh today joined 55 other state and territory attorneys general in urging Congress to reauthorize the Violence Against Women Act (VAWA) before it expires this year. “Thousands of victims of [...]